Welcome to LookChem.com Sign In|Join Free

CAS

  • or

18942-49-9

Post Buying Request

18942-49-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

18942-49-9 Usage

Description

BOC-D-Phenylalanine is the BOC (tert-butyloxycarbonyl) protected form of D-phenylalanine. It can be used in the synthesis of benzo[de][1,7] napthyridinones as PARP1 inhibitors. It is also an important reagent during the manufacturing of proline-containing, ?-turn mimetic cycle tetrapeptides.

Chemical Properties

white fine crystalline powder

Uses

Different sources of media describe the Uses of 18942-49-9 differently. You can refer to the following data:
1. Boc-D-Phenylalanine is used in the synthesis of benzo[de][1,7]napthyridinones as PARP1 inhibitors. Also it is an important reagent in the preparation of proline-containing, β-turn mimetic cycle tetrap eptides.
2. Boc-D-Phenylalanine is used in the synthesis of benzo[de][1,7]napthyridinones as PARP1 inhibitors. Also it is an important reagent in the preparation of proline-containing, β-turn mimetic cycle tetrapeptides.

References

https://www.clearsynth.com/en/CST07663.html http://www.biocompare.com/Protein-Biochemistry/10318-Boc-Protected-Phenylalanine-Monomers-and-Derivatives/

Check Digit Verification of cas no

The CAS Registry Mumber 18942-49-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,9,4 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 18942-49:
(7*1)+(6*8)+(5*9)+(4*4)+(3*2)+(2*4)+(1*9)=139
139 % 10 = 9
So 18942-49-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H19NO4/c1-14(2,3)19-13(18)15-11(12(16)17)9-10-7-5-4-6-8-10/h4-8,11H,9H2,1-3H3,(H,15,18)(H,16,17)/p-1/t11-/m1/s1

18942-49-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B2989)  N-(tert-Butoxycarbonyl)-D-phenylalanine  >98.0%(T)

  • 18942-49-9

  • 5g

  • 440.00CNY

  • Detail
  • TCI America

  • (B2989)  N-(tert-Butoxycarbonyl)-D-phenylalanine  >98.0%(T)

  • 18942-49-9

  • 25g

  • 1,290.00CNY

  • Detail
  • Alfa Aesar

  • (L08722)  N-Boc-D-phenylalanine, 98%   

  • 18942-49-9

  • 1g

  • 210.0CNY

  • Detail
  • Alfa Aesar

  • (L08722)  N-Boc-D-phenylalanine, 98%   

  • 18942-49-9

  • 5g

  • 761.0CNY

  • Detail
  • Aldrich

  • (15484)  Boc-D-Phe-OH  ≥99.0% (sum of enantiomers, TLC)

  • 18942-49-9

  • 15484-5G

  • 651.69CNY

  • Detail

18942-49-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoic acid

1.2 Other means of identification

Product number -
Other names (R)-N-(tert-butoxycarbonyl)phenylalanine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:18942-49-9 SDS

18942-49-9Relevant articles and documents

Enantiomeric discrimination of α-hydroxy acids and N-Ts-α-amino acids by1H NMR spectroscopy

Gao, Guangpeng,Lv, Caixia,Li, Qiuju,Ai, Lin,Zhang, Jiaxin

, p. 6742 - 6746 (2015)

A new kind of chiral compounds with multiple amino, amido and phenolic hydroxy groups has been synthesized from D-phenylalanine and D-phenylglycine, respectively. The enantiomeric discriminations of α-hydroxy acids and N-Ts-α-amino acids have been finished in the presence of the above chiral compounds as chiral solvating agents by1H NMR spectroscopy. The results show that the chiral compounds are highly effective and practical chiral solvating agents towards α-hydroxy acids and N-Ts-α-amino acids.

Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts

Le Manach, Claire,Dam, Jean,Woodland, John G.,Kaur, Gurminder,Khonde, Lutete P.,Brunschwig, Christel,Njoroge, Mathew,Wicht, Kathryn J.,Horatscheck, André,Paquet, Tanya,Boyle, Grant A.,Gibhard, Liezl,Taylor, Dale,Lawrence, Nina,Yeo, Tomas,Mok, Sachel,Eastman, Richard T.,Dorjsuren, Dorjbal,Talley, Daniel C.,Guo, Hui,Simeonov, Anton,Reader, Janette,Van Der Watt, Mari?tte,Erlank, Erica,Venter, Nelius,Zawada, Jacek W.,Aswat, Ayesha,Nardini, Luisa,Coetzer, Theresa L.,Lauterbach, Sonja B.,Bezuidenhout, Belinda C.,Theron, Anjo,Mancama, Dalu,Koekemoer, Lizette L.,Birkholtz, Lyn-Marie,Wittlin, Sergio,Delves, Michael,Ottilie, Sabine,Winzeler, Elizabeth A.,Smith, Dennis,Fidock, David A.,Street, Leslie J.,Basarab, Gregory S.,Duffy, James,Chibale, Kelly

, p. 2291 - 2309 (2021/03/01)

A novel diazaspiro[3.4]octane series was identified from a Plasmodium falciparum whole-cell high-throughput screening campaign. Hits displayed activity against multiple stages of the parasite lifecycle, which together with a novel sp3-rich scaffold provided an attractive starting point for a hit-to-lead medicinal chemistry optimization and biological profiling program. Structure-activity-relationship studies led to the identification of compounds that showed low nanomolar asexual blood-stage activity (50 nM) together with strong gametocyte sterilizing properties that translated to transmission-blocking activity in the standard membrane feeding assay. Mechanistic studies through resistance selection with one of the analogues followed by whole-genome sequencing implicated the P. falciparum cyclic amine resistance locus in the mode of resistance.

Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry

Guilinger, John P.,Archna, Archna,Augustin, Martin,Bergmann, Andreas,Centrella, Paolo A.,Clark, Matthew A.,Cuozzo, John W.,D?ther, Maike,Guié, Marie-Aude,Habeshian, Sevan,Kiefersauer, Reiner,Krapp, Stephan,Lammens, Alfred,Lercher, Lukas,Liu, Julie,Liu, Yanbin,Maskos, Klaus,Mrosek, Michael,Pflügler, Klaus,Siegert, Markus,Thomson, Heather A.,Tian, Xia,Zhang, Ying,Konz Makino, Debora L.,Keefe, Anthony D.

supporting information, (2021/06/15)

Libraries of DNA-Encoded small molecules created using combinatorial chemistry and synthetic oligonucleotides are being applied to drug discovery projects across the pharmaceutical industry. The majority of reported projects describe the discovery of reve

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 18942-49-9